TriGH Complex
$88.12
Contains (per vial):
6mg hGH Fragment 176–191
3mg ModGRF (1–29) (CJC-1295 without DAC)
3mg Ipamorelin
This synergistic peptide formulation is designed for research exploring growth hormone (GH) secretagogue activity, lipolysis, and anabolic signaling. hGH Fragment 176–191 is a modified C-terminal fragment of human growth hormone that selectively promotes fat metabolism without impacting insulin sensitivity. ModGRF (1–29), a tetrasubstituted analog of GHRH, enhances pituitary GH release through GHRH receptor activation, while Ipamorelin—a selective GHSR agonist—further amplifies pulsatile GH output with minimal prolactin or cortisol elevation. Together, this triad supports investigations into GH-dependent pathways, body composition modulation, and recovery dynamics.
Supplied as a lyophilized acetate salt. For laboratory research use only. Not for human or veterinary applications.
Solubility: Soluble in sterile water or bacteriostatic water. Reconstitution should occur under aseptic, low-oxygen conditions to preserve integrity.
Description
Growth Hormone Secretagogue Blend
(hGH Fragment 176–191 + Mod GRF 1-29 + Ipamorelin)
Contents (per vial):
- 6 mg hGH Fragment 176–191
- 3 mg ModGRF (1–29) (CJC-1295 without DAC)
- 3 mg Ipamorelin
Structural Characteristics:
This synergistic peptide formulation combines three growth hormone secretagogues with complementary actions:
- hGH Fragment 176–191 – a C-terminal fragment of hGH, modified to selectively promote lipolysis without increasing IGF-1.
- ModGRF (1–29) – a stabilized GHRH analog optimized for physiological GH pulse stimulation.
- Ipamorelin – a selective GHS-R1a (ghrelin receptor) agonist with minimal effect on cortisol or prolactin.
Mechanism of Action (Research Context):
Designed to emulate natural GH release patterns through dual stimulation of GHRH and ghrelin receptors, this blend supports research into:
- Lipolytic and metabolic regulation
- GH secretion dynamics and endocrine function
- Lean body mass and muscle preservation
- Combined upstream GH secretagogue pathways
Synthesis and Quality Control:
- Produced using solid-phase peptide synthesis (SPPS)
- HPLC-purified to ≥98%
- Verified by Mass Spectrometry (MS)
Product Details:
- Form: Lyophilized acetate salt blend
- Appearance: White to off-white powder
- Supplied in: 3mL sterile vial
Solubility & Reconstitution:
This product is highly sensitive to pH and oxygen exposure.
- For optimal reconstitution, use sterile bacteriostatic water with pH between 5.0–6.0
- Higher pH or prolonged air exposure may result in gelling or peptide aggregation
- Reconstituted solutions should be gently swirled; avoid vigorous shaking or aeration
Storage & Handling:
- Store lyophilized powder at –20°C, protected from light and moisture
- After reconstitution, refrigerate at 2–8°C for up to 30 days
- For long-term storage, aliquot and freeze at –20°C
- Avoid repeated freeze-thaw cycles or prolonged exposure to air
Disclaimer:
For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic applications.
Additional information
| Weight | .06 lbs |
|---|---|
| Dimensions | .5 × .5 × 1 in |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.